SEC Form 4 · accession 0001179110-15-013463
Assertio Therapeutics, Inc · ASRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James A Schoeneck
Officer — President and CEO · Director
Period of report
Sep 29, 2015
Accepted (ET)
Sep 29, 2015 · 7:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005201
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 29, 2015 | M | 33,561 | $6.11 | A | 33,561 | D | |
| Common StockF1 | Sep 29, 2015 | M | 30,000 | $6.77 | A | 63,561 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2 | $6.11 | Sep 29, 2015 | M | 33,561 | D | — | Jan 12, 2022 | Common Stock | 33,561 | 12,887 | D |
| Stock OptionF3 | $6.77 | Sep 29, 2015 | M | 30,000 | D | — | Feb 7, 2023 | Common Stock | 30,000 | 166,000 | D |
Explanation of responses
- F1Amount does not include 283,327 shares of common stock held indirectly by family trust.
- F2111,000 stock options were granted on 01/12/2012 and become exercisable in equal monthly installments for the 48 months thereafter. The stock options exercised on September 29, 2015 were Non-qualified Stock Options(NSOs).
- F3196,000 stock options were granted on 02/7/2013 and become exercisable in equal monthly installments for the 48 months thereafter. The stock options exercised on September 29, 2015 were Non-qualified Stock Options(NSOs).